Post-discontinuation Survival in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Pooled Analysis of Prospective Cohort Studies.

Inoue Y, Kitahara Y, Karayama M, Asada K, Nishimoto K, Matsuura S, Hashimoto D, Fujii M, Matsui T, Inami N, Toyoshima M, Matsuda H, Ikeda M, Niwa M, Kaida Y, Sato M, Ito Y, Yasui H, Suzuki Y, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Suda T

Open source

DOI: 10.1016/j.jtocrr.2025.100847
Published: 2025 Aug
Container: JTO clinical and research reports
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jtocrr.2025.100847,
  title = {Post-discontinuation Survival in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Pooled Analysis of Prospective Cohort Studies.},
  author = {Inoue Y and Kitahara Y and Karayama M and Asada K and Nishimoto K and Matsuura S and Hashimoto D and Fujii M and Matsui T and Inami N and Toyoshima M and Matsuda H and Ikeda M and Niwa M and Kaida Y and Sato M and Ito Y and Yasui H and Suzuki Y and Hozumi H and Furuhashi K and Enomoto N and Fujisawa T and Inui N and Suda T},
  year = {2025},
  journal = {JTO clinical and research reports},
  doi = {10.1016/j.jtocrr.2025.100847},
  url = {https://doi.org/10.1016/j.jtocrr.2025.100847}
}

RIS

TY  - JOUR
TI  - Post-discontinuation Survival in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Pooled Analysis of Prospective Cohort Studies.
AU  - Inoue Y
AU  - Kitahara Y
AU  - Karayama M
AU  - Asada K
AU  - Nishimoto K
AU  - Matsuura S
AU  - Hashimoto D
AU  - Fujii M
AU  - Matsui T
AU  - Inami N
AU  - Toyoshima M
AU  - Matsuda H
AU  - Ikeda M
AU  - Niwa M
AU  - Kaida Y
AU  - Sato M
AU  - Ito Y
AU  - Yasui H
AU  - Suzuki Y
AU  - Hozumi H
AU  - Furuhashi K
AU  - Enomoto N
AU  - Fujisawa T
AU  - Inui N
AU  - Suda T
PY  - 2025
JO  - JTO clinical and research reports
DO  - 10.1016/j.jtocrr.2025.100847
UR  - https://doi.org/10.1016/j.jtocrr.2025.100847
ER  -

APA

Y, I., Y, K., M, K., K, A., K, N., S, M., D, H., M, F., T, M., N, I., M, T., H, M., M, I., M, N., Y, K., M, S., Y, I., H, Y., Y, S., H, H., K, F., N, E., T, F., N, I., & T, S. (2025). Post-discontinuation Survival in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Pooled Analysis of Prospective Cohort Studies.. JTO clinical and research reports. https://doi.org/10.1016/j.jtocrr.2025.100847

Source records

pubmed · retrieved 2026-09-26T02:24:22.846Z